These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7514377)
1. Biological evaluation of JMV180 cholecystokinin analogs. Amblard M; Lignon MF; Bernad N; Noel-Artis AM; Hauad L; Laur J; Rodriguez M; Galas MC; Fourmy D; Martinez J Ann N Y Acad Sci; 1994 Mar; 713():79-87. PubMed ID: 7514377 [No Abstract] [Full Text] [Related]
2. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546 [TBL] [Abstract][Full Text] [Related]
3. Novel CCK analogs for studying CCK-B receptor. Yanaihara C; Kuwahara A; Suzuki M; Hoshino M; Li M; Zheng LQ; Kashimoto K; Takeda Y; Iguchi K; Mochizuki T Ann N Y Acad Sci; 1994 Mar; 713():107-17. PubMed ID: 8185151 [No Abstract] [Full Text] [Related]
4. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues. Lignon MF; Galas MC; Rodriguez M; Martinez J Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321 [TBL] [Abstract][Full Text] [Related]
5. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Saluja AK; Saluja M; Printz H; Zavertnik A; Sengupta A; Steer ML Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8968-71. PubMed ID: 2479032 [TBL] [Abstract][Full Text] [Related]
6. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin. Fulcrand P; Rodriguez M; Galas MC; Lignon MF; Laur J; Aumelas A; Martinez J Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231 [TBL] [Abstract][Full Text] [Related]
7. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides. Vinayek R; Jensen RT; Gardner JD Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164 [TBL] [Abstract][Full Text] [Related]
8. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851 [TBL] [Abstract][Full Text] [Related]
9. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123 [No Abstract] [Full Text] [Related]
10. Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors. Hruby VJ; Fang SA; Knapp R; Kazmierski W; Lui GK; Yamamura HI Int J Pept Protein Res; 1990 Jun; 35(6):566-73. PubMed ID: 2401597 [TBL] [Abstract][Full Text] [Related]
11. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Sato S; Stark HA; Martinez J; Beaven MA; Jensen RT; Gardner JD Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells. Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region. Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720 [TBL] [Abstract][Full Text] [Related]
14. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Sarri E; Ramos B; Salido GM; Claro E Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity. Galas MC; Lignon MF; Rodriguez M; Mendre C; Fulcrand P; Laur J; Martinez J Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468 [TBL] [Abstract][Full Text] [Related]
16. Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. Reeve JR; Eysselein VE; Ho FJ; Chew P; Vigna SR; Liddle RA; Evans C Ann N Y Acad Sci; 1994 Mar; 713():11-21. PubMed ID: 7514372 [TBL] [Abstract][Full Text] [Related]
17. N-methylated analogs of Ac[Nle28,31]CCK(26-33): synthesis, activity, and receptor selectivity. Ron D; Gilon C; Hanani M; Vromen A; Selinger Z; Chorev M J Med Chem; 1992 Jul; 35(15):2806-11. PubMed ID: 1495013 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683 [TBL] [Abstract][Full Text] [Related]
19. CCK8-evoked Ca2+ mobilization in pancreatic acinar cells. Evidence for a regulatory role of protein kinase C by phosphorylation-dependent inhibition of signaling through the high-affinity CCK receptor. Willems PH; van Hoof HJ; van Mackelenbergh MG; Hoenderop JG; van Emst-de Vries SE; De Pont JJ Ann N Y Acad Sci; 1994 Mar; 713():343-5. PubMed ID: 8185182 [No Abstract] [Full Text] [Related]
20. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]